Bioventus Inc expected to post breakeven results a share - Earnings Preview

Bioventus

04/08/2023 19:34

* Bioventus Inc  BVS.OQ   BVS.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 8. 
    * The Durham North Carolina-based  company is expected to
report 
a 7.9% decrease in revenue to $129.234 million from $140.33
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bioventus Inc is
for
breakeven results per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioventus
Inc is
$3.5​, below​ its last closing price of $3.56. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.15       -0.15      -0.26     Missed  -73.3
 Dec. 31 2023  0.05        0.05       -0.06     Missed  -226.3
 Sep. 30 2022  0.12        0.12       0.08      Missed  -34.4​
 Jun. 30 2022  0.15        0.16       0.10      Missed  -35.9
 ​​Mar.        0.05        0.05       0.04      Missed  -16.7
 31 2022                                                
 Dec. 31 2021  0.17        0.18       0.26      Beat    46.5​
 Sep. 30 2021  0.14        0.14       0.25      Beat    78.6
 Jun. 30 2021  0.10        0.14       0.16      Beat    16.4
 This summary was machine generated August 4 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated